Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Clinical trial NCT06227728 · RECRUITING

Trial details

NCT number: NCT06227728
Sponsor: Gene Solutions
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Breast Cancer Colorectal Cancer Gastric Cancer Liver Cancer Advanced Cancer Immune Checkpoint Inhibitor

Start date: 2024-03-22
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.